Jean‐Claude Becker

Statistics

Publications

Citations

5.7K

H-Index

Active since

1973

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Center for Rheumatology

University of Leeds

University of Alabama at Birmingham

Bristol-Myers Squibb (United States)

Jean‐Claude Becker is an author at Bristol-Myers Squibb (Germany) specializing in rheumatology, rheumatoid arthritis pharmacotherapy, and rheumatoid arthritis therapy.

Publications per year

1973–2016

Publications

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Joel M. Kremer, René Westhovens, Marc Léon et al. · New England Journal of Medicine · 2003 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis

Joel M. Kremer, Harry K. Genant, Larry W. Moreland et al. · Annals of Internal Medicine · 2006 · 714 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve‐month results of a phase iib, double‐blind, randomized, placebo‐controlled trial

Joel M. Kremer, Maxime Dougados, Paul Emery et al. · Arthritis & Rheumatism · 2005 · 446 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five days after the first infusion

Larry W. Moreland, Rieke Alten, Filip Van den Bosch et al. · Arthritis & Rheumatism · 2002 · 384 citations

Life Sciences, Immunology, Pharmacology +17

1–5 of 18